Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-005299

Director sold 10,000 shares at $7.05 ($70,500)

  • Director acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
NEUPERT PETER M Director 2025-03-10 Option exercise +50,000 $4.07 $203,500 234,690 D
NEUPERT PETER M Director 2025-03-10 Sale −10,000 $7.05 $70,500 224,690 D
Derivatives
NEUPERT PETER M Director 2025-03-10 Option exercise · Stock Option (right to buy) −50,000 0 D
Open-market sales · 10,000 sh · avg $7.05 · $70,500
Loading xslF345X05/form4.xml…